Literature DB >> 15963203

Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement.

H Oflaz1, F Mercanoglu, O Karaman, S Kamali, B Erer, H Genchellac, B Pamukcu, S Umman, M Inanc, A Gul.   

Abstract

Brachial artery endothelial dysfunction was shown previously in a small group of Behçet's disease (BD) patients. This study aimed to compare the endothelial function in BD patients with and without vascular involvement. The study group consisted of 25 BD patients with vascular involvement, 25 BD patients without any vascular disease and 46 healthy controls. Brachial artery flow-mediated (endothelium-dependent) dilation (FMD), nitroglycerine-induced dilation and carotid artery intima-media thickness were measured. FMD was impaired in patients with BD (10.41 +/- 3.85%) compared to healthy controls (14.41 +/- 3.39%, p < 0.001). FMD was significantly lower in BD patients with vascular involvement (8.80 +/- 3.63%) than those without any vascular disease (12.02 +/- 3.43%, p = 0.003). This study reveals that endothelial dysfunction documented by brachial artery FMD is a feature of BD, and it is more prominent in patients with vascular involvement.

Entities:  

Mesh:

Year:  2005        PMID: 15963203     DOI: 10.1111/j.1742-1241.2005.00477.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

Review 1.  The unique features of vasculitis in Behçet's syndrome.

Authors:  Melike Melikoglu; Emire Kural-Seyahi; Koray Tascilar; Hasan Yazici
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  Neuro-Behcet's syndrome: Case report and literature review.

Authors:  Brian Peine; Christian Figueroa; Natasha Robinette
Journal:  Radiol Case Rep       Date:  2022-06-21

Review 3.  Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.

Authors:  Nobutaka Noto; Akiko Komori; Mamoru Ayusawa; Shori Takahashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

4.  Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behçet's disease.

Authors:  Rifat Eralp Ulusoy; Ozlem Karabudak; Fethi Kilicaslan; Ata Kirilmaz; Melih Hulusi Us; Bekir Sitki Cebeci
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

5.  Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Authors:  Ismail Sari; Oguzhan Karaoglu; Gercek Can; Servet Akar; Aytac Gulcu; Merih Birlik; Nurullah Akkoc; Mehmet Tunca; Yigit Goktay; Fatos Onen
Journal:  Clin Rheumatol       Date:  2007-01-23       Impact factor: 3.650

Review 6.  An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.

Authors:  Thomas W McNally; Erika M Damato; Philip I Murray; Alastair K Denniston; Robert J Barry
Journal:  Orphanet J Rare Dis       Date:  2017-07-17       Impact factor: 4.123

7.  The risk of endothelial and erectile dysfunctions in Behçet's disease: a comparative analysis of mucocutaneous and systemic patient groups.

Authors:  Yasemin Erdem; Selcuk Erdem; Mehmet Barburoglu; Ekrem Bilal Karaayvaz; Erkingul Shugaiv; Murat Kurtuncu; Artur Salmaslioglu; Huseyin Oflaz; Afet Akdag Kose; Ates Kadioglu
Journal:  Postepy Dermatol Alergol       Date:  2021-09-17       Impact factor: 1.837

8.  Common carotid artery intima-media thickness is useful for diagnosis of the acute stage of Kawasaki disease.

Authors:  Ting-Hsin Wu; Hsuan-Chang Kuo; You-Lin Tain; Kuan-Miao Lin; Ho-Chang Kuo; Shao-Ju Chien
Journal:  BMC Pediatr       Date:  2014-04-10       Impact factor: 2.125

9.  Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Authors:  Lei Qin; Yi-Wei Kao; Yueh-Lung Lin; Bou-Yue Peng; Win-Ping Deng; Tsung-Ming Chen; Kuan-Chou Lin; Kevin Sheng-Po Yuan; Alexander T H Wu; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2018-07-15       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.